CIDRAP: Small Study Finds
Colchicine Improves Outcomes In COVID-19 Patients
Colchicine appeared to be safe and effective in treating moderate to severe
COVID-19 infections in hospitalized patients, according to a randomized,
double-blind clinical trial published yesterday in RMD Open. Patients who took
the inexpensive drug, which is commonly used to treat gout, required
supplemental oxygen and hospitalization for less time. (2/5)
No comments:
Post a Comment